Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-018740

Senior Vice President and CFO sold 11,750 shares at an average $7.81 ($91,710)

  • Senior Vice President and CFO acquired 9,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-14 Exercise or conversion : show line 1 in the form +4,500 $1.42 $6,390 137,176 D
2019-05-14 Sale : show line 2 in the form −4,500 $7.62 $34,290 132,676 D
2019-05-15 Exercise or conversion : show line 3 in the form +4,750 $1.42 $6,745 137,426 D
2019-05-15 Sale : show line 4 in the form −7,250 $7.92 $57,420 130,176 D
Open-market sales · 11,750 sh · avg $7.81 · $91,710

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-05-14 Exercise or conversion : show line 5 in the form Emp. Stock Option (Right to Buy) −4,500 70,500 D
2019-05-15 Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) −4,750 65,750 D
Loading xslF345X03/form4.xml…